Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer

909.6000 10.40 (1.16%)

NSE Sep 02, 2025 15:48 PM

New 52W Low in past week

Volume: 125.7K

High vol. this week

Cohance Lifesciences Ltd.

13 Jun 2024

909.60

1.16%

Company Update

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI LODR regarding Acquisition

More from Cohance Lifesciences Ltd.

Recommended

Market closes lower, Trident to acquire a 30% stake in Trident Global for Rs 250 crore

Trendlyne Marketwatch | 02 Sep 2025, 04:00PM

IPO activity stays steady with Amanta and seven SME issues opening this week

| 02 Sep 2025, 11:38AM

Five Interesting Stocks Today - August 29, 2025

The Baseline | 29 Aug 2025